An observational study in Migraine Disorders and Headache, sponsored by Allergan. Completed at 1 site in United States. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2016-03-15.
Sponsored by Allergan · Observational
This study is a retrospective chart review in patients diagnosed with headache or migraine to evaluate treatment patterns and diagnosis.
1,528 studies on the registry are indexed under Migraine Disorders; 299 are open to participants now.
This study's enrollment of 459 is above the median of 130 across 299 observational studies indexed under Migraine Disorders.
Browse Migraine Disorders studies →Allergan is the lead sponsor of 499 studies on the registry; none are open to participants now.
Of its 91 completed or terminated interventional studies of FDA-regulated products, 89 (98%) have results posted.
Counted across the registry records on this site, refreshed daily.
Patients with a diagnosis of chronic migraine or other diagnosis of migraine or headache.
Exclusion Criteria:
This is a retrospective chart review for patients diagnosed with Chronic Migraine. There is no intervention in this study.
Other: No Intervention
This is a retrospective chart review of patients with headache diagnoses other than Chronic Migraine. There is no intervention in this study.
Other: No Intervention
There is no intervention in this study.
Presence or Absence of Prophylactic Medication for Headache/Migraine
The presence or absence of prophylactic medications used by the subject for headache/migraine is evaluated through the study period.
Time frame: 15 Months
Number of Unique Prophylactic Medications for Headache/Migraine Reported
The numbers of unique prophylactic medications used by the subjects for headache/migraine are evaluated through the study period.
Time frame: 15 Months
Number of Days With a Headache Recorded at the Visit With the Highest Number of Headaches
The number of headache days is reported at the visit with the highest number of headaches.
Time frame: 15 Months
Highest Number of Headache Days Per Month at a Qualifying Visit
The highest number of headache days per month are reported at a qualifying visit per the medical record.
Time frame: 15 Months
Number of Visits for Headache Diagnosis
The number of visits for headache diagnosis is evaluated through the study period.
Time frame: 15 Months
| Milestone | Chronic Migraine Diagnosis | Other Headache Diagnoses |
|---|---|---|
| Started | 184 | 275 |
| Completed | 184 | 275 |
| Not completed | 0 | 0 |
The presence or absence of prophylactic medications used by the subject for headache/migraine is evaluated through the study period.
| Participants | Chronic Migraine Diagnosis | Other Headache Diagnoses |
|---|---|---|
| Presence of Prophylactic Medication | 166 | 227 |
| Absence of Prophylactic Medication | 18 | 48 |
The numbers of unique prophylactic medications used by the subjects for headache/migraine are evaluated through the study period.
| Medications | Chronic Migraine Diagnosis | Other Headache Diagnoses |
|---|---|---|
| Number of Unique Prophylactic Medications for Headache/Migraine Reported | 2.7 ± 1.49 | 1.8 ± 1.27 |
The number of headache days is reported at the visit with the highest number of headaches.
| Headache Days | Chronic Migraine Diagnosis | Other Headache Diagnoses |
|---|---|---|
| Number of Days With a Headache Recorded at the Visit With the Highest Number of Headaches | 22.0 (20.6 to 23.4) | 19.2 (18.2 to 20.2) |
The highest number of headache days per month are reported at a qualifying visit per the medical record.
| Days | Chronic Migraine Diagnosis | Other Headache Diagnoses |
|---|---|---|
| Highest Number of Headache Days Per Month at a Qualifying Visit | 16.28 (14.4 to 18.2) | 14.01 (12.6 to 15.4) |
The number of visits for headache diagnosis is evaluated through the study period.
| Visits | Chronic Migraine Diagnosis | Other Headache Diagnoses |
|---|---|---|
| Number of Visits for Headache Diagnosis | 4.7 ± 2.5 | 3.5 ± 1.63 |
Non-serious events are listed at a 5% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| Chronic Migraine Diagnosis | — | — | — |
| Other Headache Diagnoses | — | — | — |
| Age, Continuous(Years) | Chronic Migraine Diagnosis | Other Headache Diagnoses | Total |
|---|---|---|---|
| Mean | 45.02 ± 11.54 | 45.44 ± 11.62 | 45.3 ± 11.58 |
| Sex/Gender, Customized(Participants) | Chronic Migraine Diagnosis | Other Headache Diagnoses | Total |
|---|---|---|---|
| Number | NA | NA | NA |
This study is completed, as verified in Feb 2016. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Allergan